TY - JOUR
T1 - An atherogenic diet disturbs aquaporin 5 expression in liver and adipocyte tissues of apolipoprotein e-deficient mice
T2 - new insights into an old model of experimental atherosclerosis
AU - da Silva, Inês V.
AU - Whalen, Courtney A.
AU - Mattie, Floyd J.
AU - Florindo, Cristina
AU - Huang, Neil K.
AU - Heil, Sandra G.
AU - Neuberger, Thomas
AU - Catharine Ross, A.
AU - Soveral, Graça
AU - Castro, Rita
N1 - Funding Information:
Funding: This work was funded by the Graduate Program in Nutritional Sciences, Penn State High-Field Magnetic Resonance Imaging Facility, and the Huck Institutes of the Life Sciences, all from the Pennsylvania State University, USA, as well as by the Fundação para a Ciência e Tecnologia (FCT), Portugal (grant PTDC/BTM-SAL/28977/2017 and strategic projects UIDB/04138/2020 and UIDP/04138/2020), and publication funds were from The Hershey Company Endowment in Nutrition.
Publisher Copyright:
© 2021 by the authors. Licensee MDPI, Basel, Switzerland.
PY - 2021/2
Y1 - 2021/2
N2 - The dysfunction of vascular endothelial cells is profoundly implicated in the pathogenesis of atherosclerosis and cardiovascular disease, the global leading cause of death. Aquaporins (AQPs) are membrane channels that facilitate water and glycerol transport across cellular membranes re-cently implicated in the homeostasis of the cardiovascular system. Apolipoprotein-E deficient (apoE−/−) mice are a common model to study the progression of atherosclerosis. Nevertheless, the pattern of expression of AQPs in this atheroprone model is poorly characterized. In this study, apoE−/− mice were fed an atherogenic high-fat (HF) or a control diet. Plasma was collected at multiple time points to assess metabolic disturbances. At the endpoint, the aortic atherosclerotic burden was quantified using high field magnetic resonance imaging. Moreover, the transcriptional levels of several AQP isoforms were evaluated in the liver, white adipocyte tissue (WAT), and brown adipocyte tissue (BAT). The results revealed that HF-fed mice, when compared to controls, presented an ex-acerbated systemic inflammation and atherosclerotic phenotype, with no major differences in systemic methylation status, circulating amino acids, or plasma total glutathione. Moreover, an over-expression of the isoform AQP5 was detected in all studied tissues from HF-fed mice when compared to controls. These results suggest a novel role for AQP5 on diet-induced atherosclerosis that warrants further investigation.
AB - The dysfunction of vascular endothelial cells is profoundly implicated in the pathogenesis of atherosclerosis and cardiovascular disease, the global leading cause of death. Aquaporins (AQPs) are membrane channels that facilitate water and glycerol transport across cellular membranes re-cently implicated in the homeostasis of the cardiovascular system. Apolipoprotein-E deficient (apoE−/−) mice are a common model to study the progression of atherosclerosis. Nevertheless, the pattern of expression of AQPs in this atheroprone model is poorly characterized. In this study, apoE−/− mice were fed an atherogenic high-fat (HF) or a control diet. Plasma was collected at multiple time points to assess metabolic disturbances. At the endpoint, the aortic atherosclerotic burden was quantified using high field magnetic resonance imaging. Moreover, the transcriptional levels of several AQP isoforms were evaluated in the liver, white adipocyte tissue (WAT), and brown adipocyte tissue (BAT). The results revealed that HF-fed mice, when compared to controls, presented an ex-acerbated systemic inflammation and atherosclerotic phenotype, with no major differences in systemic methylation status, circulating amino acids, or plasma total glutathione. Moreover, an over-expression of the isoform AQP5 was detected in all studied tissues from HF-fed mice when compared to controls. These results suggest a novel role for AQP5 on diet-induced atherosclerosis that warrants further investigation.
UR - http://www.scopus.com/inward/record.url?scp=85100828587&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85100828587&partnerID=8YFLogxK
U2 - 10.3390/biomedicines9020150
DO - 10.3390/biomedicines9020150
M3 - Article
C2 - 33557105
AN - SCOPUS:85100828587
SN - 2227-9059
VL - 9
SP - 1
EP - 16
JO - Biomedicines
JF - Biomedicines
IS - 2
M1 - 150
ER -